Correlation Between Eonmetall Group and Duopharma Biotech
Can any of the company-specific risk be diversified away by investing in both Eonmetall Group and Duopharma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eonmetall Group and Duopharma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eonmetall Group Bhd and Duopharma Biotech Bhd, you can compare the effects of market volatilities on Eonmetall Group and Duopharma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eonmetall Group with a short position of Duopharma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eonmetall Group and Duopharma Biotech.
Diversification Opportunities for Eonmetall Group and Duopharma Biotech
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eonmetall and Duopharma is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Eonmetall Group Bhd and Duopharma Biotech Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Duopharma Biotech Bhd and Eonmetall Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eonmetall Group Bhd are associated (or correlated) with Duopharma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Duopharma Biotech Bhd has no effect on the direction of Eonmetall Group i.e., Eonmetall Group and Duopharma Biotech go up and down completely randomly.
Pair Corralation between Eonmetall Group and Duopharma Biotech
Assuming the 90 days trading horizon Eonmetall Group Bhd is expected to under-perform the Duopharma Biotech. In addition to that, Eonmetall Group is 2.29 times more volatile than Duopharma Biotech Bhd. It trades about -0.04 of its total potential returns per unit of risk. Duopharma Biotech Bhd is currently generating about 0.01 per unit of volatility. If you would invest 120.00 in Duopharma Biotech Bhd on November 2, 2024 and sell it today you would earn a total of 1.00 from holding Duopharma Biotech Bhd or generate 0.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eonmetall Group Bhd vs. Duopharma Biotech Bhd
Performance |
| Timeline |
| Eonmetall Group Bhd |
| Duopharma Biotech Bhd |
Eonmetall Group and Duopharma Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eonmetall Group and Duopharma Biotech
The main advantage of trading using opposite Eonmetall Group and Duopharma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eonmetall Group position performs unexpectedly, Duopharma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Duopharma Biotech will offset losses from the drop in Duopharma Biotech's long position.| Eonmetall Group vs. YX Precious Metals | Eonmetall Group vs. Senheng New Retail | Eonmetall Group vs. Farm Price Holdings | Eonmetall Group vs. Dataprep Holdings Bhd |
| Duopharma Biotech vs. Apex Healthcare Bhd | Duopharma Biotech vs. Nexgram Holdings Bhd | Duopharma Biotech vs. Techfast Holdings Bhd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |